PLASMA Act
3/21/2025, 2:06 PMSummary of Bill HR 1476
Bill 119 HR 1476, also known as the Plasma-Derived Products Manufacturer Discount Program Phase-In Act, aims to amend Title XVIII of the Social Security Act. The main goal of this bill is to provide a gradual implementation process for plasma-derived products under the manufacturer discount program.Currently, plasma-derived products are not included in the manufacturer discount program, which provides discounts to certain drugs for Medicare beneficiaries. This bill seeks to change that by gradually phasing in plasma-derived products into the program.
The bill outlines a specific timeline for this phase-in process, ensuring that manufacturers of plasma-derived products have time to adjust to the new requirements. This gradual implementation is intended to prevent any disruptions in the availability of these important medical products for Medicare beneficiaries. Overall, the Plasma-Derived Products Manufacturer Discount Program Phase-In Act aims to improve access to plasma-derived products for Medicare beneficiaries while also ensuring that manufacturers have the necessary time to comply with the new requirements.
Read the Full Bill
Current Status of Bill HR 1476
Bill HR 1476 is currently in the status of Bill Introduced since February 21, 2025. Bill HR 1476 was introduced during Congress 119 and was introduced to the House on February 21, 2025. Bill HR 1476's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of February 21, 2025Bipartisan Support of Bill HR 1476
Total Number of Sponsors
4Democrat Sponsors
0Republican Sponsors
4Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
2Republican Cosponsors
1Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1476
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 1476
To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.Comments
Most relevant
Sponsors and Cosponsors of HR 1476
Latest Bills
NORRA of 2025
Bill HR 1526March 26, 2025
Emerging Digital Identity Ecosystem Report Act of 2025
Bill HR 1925March 26, 2025
Veterans Patient Advocacy Act
Bill HR 2068March 26, 2025
Filing Relief for Natural Disasters Act
Bill HR 517March 26, 2025
Sanctuary City Accountability Act
Bill HR 1928March 26, 2025
Recognizing a century of broadcasting excellence from WOWO and celebrating the radio station's 100th anniversary.
Bill HRES 252March 26, 2025
Recognizing the significance of equal pay and the disparity between wages paid to men and women.
Bill HCONRES 21March 26, 2025
Providing for consideration of the bill (H.R. 1101) to prohibit unlawful access to the payment system of the Bureau of the Fiscal Service within the Department of the Treasury, and for other purposes.
Bill HRES 250March 26, 2025
Expressing support for the designation of the week of March 23, 2025, through March 29, 2025, as "National Cleaning Week".
Bill HRES 247March 26, 2025
Expressing support for the designation of May 15, 2025, as "Prader-Willi Syndrome Awareness Day" to raise awareness of and promote research on the disorder.
Bill HRES 253March 26, 2025
PLASMA Act
Bill S 694March 21, 2025